Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 275-283

  Talcott, James A ^a   Rieker, Patricia ^a   Clark, Jack A ^a   Propert, Kathleen J ^a   Weeks, Jane C ^a   Beard, Clair J ^a   Wishnow, Kenneth I ^a   Kaplan, Irving ^a   Loughlin, Kevin R ^a   Richie, Jerome P ^a   Kantoff, Philip W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BEAM THERAPY; BLADDER IRRITATION; CONTROLLED STUDY; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SEXUAL DYSFUNCTION; URINE INCONTINENCE;

EID: 0031972670     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.275     Document Type: Article

References (29)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1997. CA Cancer J Clin 47:5-27, 1997
2. Lu-Yao GL, McLerran D, Wasson J, et al: An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA 269:2633-2636, 1993
3. Talcott JA: Quality of life in early prostate cancer: Do we know enough to treat? Hematol Oncol Clin North Am 1996;10:691-701.
4. Boring CC, Squires TS, Tong T: Cancer statistics, 1993. CA Cancer J Clin 43:7-26, 1993
5. Chodak GW, Schoenberg HW: Early detection of prostate cancer by routine screening. JAMA 252:3261-3264, 1984
6. Kramer BS, Brown ML, Prorok PC, et al: Prostate cancer screening: What we know and what we need to know. Ann Intern Med 119:914-923, 1993
7. Gerber GS, Thompson IM, Thisted R, et al: Disease-specific survival following routine prostate cancer screening by digital rectal examination. JAMA 269:61-64, 1993
8. Walsh PC, Lepor H, Eggleston JC: Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations. Prostate 4:473-485, 1983
9. Walsh PC, Epstein JI, Lowe FC: Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol 138:823-827, 1987
10. Catalona WJ, Basler JW: Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 150:905-907, 1993
11. Steiner MS, Morton RA, Walsh PC: Impact of anatomical radical prostatectomy on urinary continence. J Urol 145:512-514, 1991
12. Schellhammer PF, El MA: Pelvic complications after definitive treatment of prostate cancer by interstitial or external beam radiation. Urology 21:451-457, 1983
13. Zinreich ES, Derogatis LR, Herpst J, et al: Pre- and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 19:729-732, 1990
14. Banker FL: The preservation of potency after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 15:219-220, 1988
15. Fowler F Jr, Barry MJ, Lu-Yao G, et al: Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology 42:622-629, 1993
16. Litwin MS, Hays RD, Fink A, et al: Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273:129-135, 1995
17. Oesterling JE, Martin SK, Bergstralh EJ, et al: The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269:57-60, 1993
18. Schmidt JD, Mettlin CJ, Natarajan N, et al: Trends in patterns of care for prostatic cancer, 1974-1983: Results of surveys by the American College of Surgeons. J Urol 136:416-421, 1986
19. Greenfield S, Aronow HU, Elashoff RM, et al: Flaws in mortality data. The hazards of ignoring comorbid disease. JAMA 260:2253-2255, 1988
20. Moinpour CM, Hayden KA, Thompson IM, et al: Quality of life assessment in Southwest Oncology Group trials. Oncology (Williston Park) 4:79-84, 1990
21. Rieker P, Clark J, Kalish L, et al: Health related quality of life following treatment for early stage prostate cancer. Proc Annu Meet Am Soc Clin Oncol 12:A1567, 1993 (abstr)
22. Talcott JA, Rieker PP, Propert KJ, et al: Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 89:1117-1123, 1997
23. Litwin M: Health-related quality of life after treatment for localized prostate cancer. Cancer 75:2000-2003, 1995
24. Moore MJ, O'Sullivan B, Tannock IF: How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 6:1736-1745, 1988
25. Walsh PC: Radical prostatectomy, preservation of sexual function, cancer control: The controversy. Urol Clin North Am 14:663-673, 1987
26. Catalona WJ, Bigg SW: Nerve-sparing radical prostatectomy: Evaluation of results after 250 patients. J Urol 143:538-543, 1990
27. Bennett CL, Greenfield S, Aronow H, et al: Patterns of care related to age of men with prostate cancer. Cancer 67:2633-2641, 1991
28. Beard CJ, Propert KJ, Rieker PP, et al: Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study. J Clin Oncol 15:223-229, 1997
29. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al: Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 14:2258-2265, 1996